BeOne Medicines Ltd.
ONC
$308.63
-$5.04-1.61%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.76B | 2.52B | 2.63B | 2.71B | 2.59B |
Total Receivables | 880.13M | 745.98M | 709.11M | 604.80M | 588.23M |
Inventory | 502.87M | 494.66M | 494.99M | 431.62M | 443.26M |
Prepaid Expenses | 41.70M | 46.28M | 49.37M | -- | 75.34M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 129.47M | 93.16M | 110.72M | 160.39M | 139.55M |
Total Current Assets | 4.31B | 3.90B | 3.99B | 3.91B | 3.84B |
|
|||||
Total Current Assets | 4.31B | 3.90B | 3.99B | 3.91B | 3.84B |
Net Property, Plant & Equipment | 1.76B | 1.75B | 1.72B | 1.58B | 1.62B |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 64.89M | 50.14M | 51.10M | 122.06M | 53.72M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 42.25M | 28.75M | 31.56M | 181.23M | 59.55M |
Total Assets | 6.30B | 5.84B | 5.92B | 5.82B | 5.71B |
|
|||||
Total Accounts Payable | 360.78M | 364.50M | 405.00M | 475.56M | 333.02M |
Total Accrued Expenses | 791.83M | 627.04M | 780.48M | 208.73M | 559.25M |
Short-term Debt | 766.53M | 725.61M | 816.95M | 832.36M | 821.02M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 59.11M | 56.17M | 52.16M | -- | 48.29M |
Total Finance Division Other Current Liabilities | 231.58M | 210.41M | 160.32M | 501.15M | 177.18M |
Total Other Current Liabilities | 231.58M | 210.41M | 160.32M | 501.15M | 177.18M |
Total Current Liabilities | 2.21B | 1.98B | 2.21B | 2.02B | 1.94B |
|
|||||
Total Current Liabilities | 2.21B | 1.98B | 2.21B | 2.02B | 1.94B |
Long-Term Debt | 146.09M | 160.16M | 166.48M | 187.76M | 185.27M |
Short-term Debt | 766.53M | 725.61M | 816.95M | 832.36M | 821.02M |
Capital Leases | 53.94M | 54.90M | 44.28M | 32.47M | 35.40M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 118.05M | 143.24M | 163.03M | 140.40M | 186.49M |
Total Liabilities | 2.53B | 2.34B | 2.59B | 2.38B | 2.35B |
|
|||||
Common Stock & APIC | 12.40B | 12.25B | 12.09B | 12.01B | 11.84B |
Retained Earnings | -8.51B | -8.61B | -8.61B | -8.75B | -8.33B |
Treasury Stock & Other | -113.70M | -142.32M | -148.99M | 182.82M | -140.47M |
Total Common Equity | 3.77B | 3.50B | 3.33B | 3.45B | 3.37B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.77B | 3.50B | 3.33B | 3.45B | 3.37B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.77B | 3.50B | 3.33B | 3.45B | 3.37B |
|